ArticlePharmaceutics2024

Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical Trial.

Chaoying Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.